Curcumin Shows a Balanced Anticancer Profile, According to Sarcoma Cell Study

Turmeric Root and Powder

  • A laboratory study from Wroclaw Medical University tested and compared five plant compounds — curcumin, berberine, biochanin A, cucurbitacin E, and CAPE — for their ability to affect fibrosarcoma cancer cells versus healthy muscle cells
  • The compounds disrupted energy production far more in the cancer cells, where adenosine triphosphate (ATP) levels dropped by roughly 83% to 92%, compared with 23% to 73% in healthy cells
  • All five pushed cancer cells into permanent growth arrest. However, curcumin stood out, producing the strongest effect, raising senescent cancer cells from about 16.5% to more than 75%
  • In a wax moth larvae safety screen, curcumin and berberine were best tolerated, while biochanin A proved most toxic, showing strong anticancer activity does not guarantee safety
  • The work used animal cell lines and a simple invertebrate model, so the researchers are clear these compounds are not a treatment for cancer and need testing in more advanced models

Keep reading: https://articles.mercola.com/sites/articles/archive/2026/10/22/curcumin-anticancer-effects-study.aspx

PCOS Reversed

PCOS Reversed

From mid-2024 through 2025, dietitians at a women’s and children’s hospital in Yangzhou, China, randomized 60 women with PCOS to two diets for 12 weeks.

PCOS affects 8 to 13% of women of reproductive age, and 50 to 70% have insulin resistance. The WHO says it cannot be cured. In May 2026, a Lancet consensus renamed it polyendocrine metabolic ovarian syndrome.

Thirty went keto: under 50 grams of carbs a day, with fats like avocado, nuts, olive oil and fatty fish. Thirty ate a China-adapted Mediterranean-style diet with whole grains, legumes and fruit, the diet the authors call most widely recommended. Both had matched calorie targets, counseling and exercise advice.

Of 13 keto women with no periods at the start, 12 got them back, versus 5 of 15 on the Mediterranean-style diet. Excluding women already regular (3 versus 12), 26 of 27 reached regular cycles on keto, versus 8 of 18. Insulin resistance fell 72% versus 35%. Frontiers in Nutrition published it in September.

Be straight about it. One hospital, 60 Chinese women, 12 weeks, open label, self-reported cycles, not yet repeated. The keto group lost about 22 pounds more on the same calorie targets, so real intake may have differed, and the authors can’t separate ketosis from weight loss and adherence.

Testosterone didn’t change. Nobody measured ovulation or pregnancy. Diabetes and thyroid patients were excluded. Zero dropouts and unbroken ketosis: unusually tidy data. The authors advise keto first, then Mediterranean long term. Never start, stop or change medication without your doctor.

The point is not that keto cures PCOS, or that the Mediterranean diet failed. Both helped. The point is that for a condition now named for its metabolism, the low-carb plate moved periods and insulin further.

The new name says metabolic. Start at the plate.

Source:https://www.facebook.com/photo?fbid=1698947074922811&set=pcb.1698948178256034

Richard Morgan

Richard Morgan

Richard Morgan had spent most of his life as a baker and battery maker. No structured training. No athletic past. At 73 he sat on an erg to kill time and a coach noticed his natural stroke. He never stopped.

By his early 90s he was a four-time indoor rowing world champion. He had rowed the equivalent of nearly ten times around the planet, mostly in a backyard shed. Researchers put him in a lab at 92 and measured what late-starting training had done.

His 165 pounds were roughly 80% muscle and 15% fat. Peak heart rate hit 153 during a 2,000 m trial—among the highest recorded for anyone in their 90s. Oxygen uptake kinetics looked like those of a healthy 30- or 40-year-old. Forced vital capacity and peak power sat well above what the textbooks predict for his age.

He trained about 30 km a week on the erg, mostly easy, with a couple of harder sessions and basic strength work. The body adapted. Muscle stayed. The cardiovascular system stayed responsive. Performance kept rising long after most people assume the window has closed.

The usual story is that you have to start young or you miss the boat. Morgan started in his seventies and collected world titles in his nineties. The systems that matter for rowing—power, oxygen delivery, muscle mass—proved more plastic than the decline curves suggest.

The Century of Evidence Putting Light Inside the Body Is A Miraculous Therapy

UVBI

Story at a Glance:

•Natural light is an essential nutrient many of us do not have enough of within our bodies. Because of this, when ultraviolet light is added to the bloodstream, phenomenal health benefits emerge.

•Once ultraviolet blood irradiation (UVBI) was discovered in the 1930s, it produced miraculous results for patients on the verge of death and was quickly adopted by hospitals throughout America. There, it demonstrated remarkable efficacy for a wide range of diseases, and the doctors who pioneered its use compiled a large body of research.

•To neutralize this competition, the American Medical Association published a small doctored study that “debunked” UVBI, and before long it became a forgotten side of medicine. The Russians and Germans however recognized the value of it, and for decades have produced research showing UBVI’s remarkable utility for a variety of challenging medical conditions both within and outside the hospital. However, in America, UVBI is primarily used by integrative practitioners who need effective tools to treat complex illnesses (e.g., Lyme disease, Chronic fatigue syndrome, spike protein injuries, or migraine disorders).

•In this article we will review the hundreds of studies showing UVBI’s utility for a wide range of medical conditions (e.g., cardiovascular diseases, infertility, preventing miscarriages, many autoimmune disorders, preventing complications from surgery, and treating a myriad of challenging bacterial and viral infections), explain how UVBI works, and provide the resources for those wishing to best utilize this therapy.

In this publication, I have attempted to make the case that we are routinely denied vital knowledge, treatment, and care, in order to protect the interests of the medical industrial complex (as you can only sell costly but abysmal therapeutics to people if no alternatives exist). As that is a rather extreme allegation to make, I’ve tried to show piece by piece how this is indeed the case. For example:

•I’ve highlighted how many unsafe and ineffective pharmaceuticals make it to market (and sometimes are even mandated) because the panels that approved them were stacked with people taking money from the manufacturer (which I recently argued was a tactic Anthony Fauci weaponized against America).

•I’ve discussed how in the early 1900s, the American Medical Association was taken over by a group of unscrupulous businessmen who decided to fund the association by unconditionally promoting anything they were paid to (which amongst other things is why there were so many AMA advertisements of doctors promoting smoking) while simultaneously using the government to outlaw each competing therapy that refused to sell out to them.

•I’ve shown how American society has been methodically separated from the fundamental requirements for good health (e.g., sleep or sunlight), how damaging losing each of those is, and just how far the marketing industry often goes to ensure we never reclaim those basic requirements for health.

Assuming the first three are indeed true, it then suggests that a variety of remarkable medical innovations exist that have been buried. In this article, I will discuss one of those, ultraviolet blood irradiation (UVBI), both because there is a vast body of evidence for its use and because, unlike many of the other lost medical technologies, it’s still relatively accessible.

Continue reading: https://www.midwesterndoctor.com/p/the-century-of-evidence-putting-light

David Franklin and Parke Davis

Parke Davis

 

David Franklin had spent months watching his company sell a drug to patients it was never approved to treat. He had the files. He had the proof. Now he had a decision to make.

The drug was Neurontin, a brand name for gabapentin. The FDA had approved it in 1993 for one narrow purpose: controlling seizures in epilepsy patients.

That was not how Parke-Davis was selling it.

Franklin worked as a medical liaison, a scientist paid to brief doctors on the evidence behind the company’s products. Beginning in 1996, he watched colleagues and supervisors instruct sales representatives to pitch Neurontin for conditions it had never been proven to treat: chronic pain, migraines, bipolar disorder, attention disorders, and more.

This was off-label promotion. It was illegal. And it was happening systematically.

Worse, Franklin discovered the company had buried the results of clinical trials that had failed to show Neurontin worked for these conditions. Doctors making prescribing decisions were not seeing the full picture. Patients were taking a drug based on hidden science.

In 1996, Franklin filed suit under the False Claims Act, a Civil War-era law that allows private citizens to sue on the government’s behalf when federal funds are defrauded. Medicaid and other federal programs were reimbursing millions of prescriptions written on the basis of the company’s misleading claims.

The legal battle ran for eight years.

Parke-Davis was acquired by Warner-Lambert. Warner-Lambert was acquired by Pfizer in 2000, one of the largest pharmaceutical companies in the world. The lawsuit followed the merger through every corporate transformation.

On May 13, 2004, Pfizer agreed to a settlement of $430 million. It included a $240 million criminal fine, the largest ever levied against a pharmaceutical company at that time for off-label marketing. Warner-Lambert entered a guilty plea.

Franklin received a portion of the civil recovery as the original whistleblower.

Neurontin remained on the market. Gabapentin is still widely prescribed. The case did not end off-label promotion in the pharmaceutical industry. But it established a legal template: individual scientists with evidence could file, survive, and win against companies many times their size.

A microbiologist. A courthouse. Eight years of waiting.

Sometimes one person with a file cabinet and a lawyer is enough.